An inhaled drug met its main goal in a 135-patient mid-stage trial for pulmonary hypertension linked to interstitial lung disease.
Inhaled Drug Cut Blood Vessel Resistance in the Lungs Fifty Six Percent in a Trial of 135 Patients
by | Sep 9, 2026 | Uncategorized | 0 comments

Recent Comments